Cutaneous Squamous Cell Carcinoma

Advances in Dermatology

Volumn 24, Issue C, 2008, Pages 33-57

  Garcia Zuazaga, Jorge ^a   Olbricht, Suzanne M ^b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; REVIEW; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HUMANS; SKIN NEOPLASMS;

EID: 56349092925     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yadr.2008.09.007     Document Type: Review

References (104)

1. Kirkham N. Tumors and cysts of the epidermis. In: Elder D., Eleritas R., Jaworsky C., et al. (Eds). Lever's histopathology of the skin (1997), Lipincott-Raven, Philadelphia 685-746
2. Lohmann C.M., and Solomon A.R. Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol 8 (2001) 27-36
3. Barksdale S.K., O'Connor N., and Barnhill R. Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Surg Oncol Clin N Am 6 (1997) 625-638
4. Preston D.S., and Stern R.S. Nonmelanoma cancers of the skin. N Engl J Med 327 (1992) 1649-1662
5. Gray D.T., Suman V.J., Siu W.P.D., et al. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 133 (1997) 735-740
6. Christenson L.J., Barrowman T.A., Vachon C.M., et al. Incidence of basal cell and squamous cell carcinoma in a population younger than 40 years. JAMA 294 (2005) 681-690
7. Staples M.P., Elwood M., Burton R.C., et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 184 (2006) 6-10
8. Demers A.A., Nugent Z., Mikhalcioiu C., et al. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 53 (2005) 320-328
9. Dinehart S.M., and Pollack S.V. Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 21 (1989) 241-248
10. Stenbeck K.D., Balanda K.P., Williams M.J., et al. Patterns of treated non-melanoma skin cancer in Queensland-the region with the highest incidence rates in the world. Med J Aust 153 (1990) 511-515
11. Magnus K. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 47 (1991) 12-19
12. Marks R., Staples M., and Giles G.G. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust 150 (1989) 475-478
13. Giles G.G., Marks P., and Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 296 (1988) 13-17
14. Holt P.J. Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol 119 (1988) 231-240
15. Scotto J., Kopf A.W., and Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer 34 (1974) 1333-1338
16. Schreiber M.M., Shapiro S., Berry C.Z., et al. The incidence of skin cancer in southern Arizona (Tucson). Arch Dermatol 104 (1971) 124-127
17. Serrano H., Scotto J., Shornick G., et al. Incidence of nonmelanoma skin cancer in New Hampshire and Vermont. J Am Acad Dermatol 24 (1991) 574-579
18. Hemminki K., Zhang H., and Czene K. Time trends and familial risks in squamous cell carcinoma of the skin. Arch Dermatol 139 (2003) 885-889
19. Ramos J., Villa J., Ruiz A., et al. UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 13 12 (2004) 2006-2011
20. Han J., Colditz G.A., Samson L.D., et al. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res 64 9 (2004) 3009-3013
21. Maier H., Schemper M., Ortel B., et al. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst 97 24 (2005) 1822-1831
22. Karagas M.R., McDonald J.A., Greenberg E.R., et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For the skin cancer prevention study group. J Natl Cancer Inst 88 24 (1996) 1848-1853
23. Struijk L., Hall L., van der Meijden E., et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 15 3 (2006) 529-535
24. Cassarino D.S., Derienzo D.P., and Barr R.J. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. J Cutan Pathol 33 3 (2006) 191-206 [review]
25. Cassarino D.S., Derienzo D.P., and Barr R.J. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification-part two. J Cutan Pathol 33 4 (2006) 261-279
26. Masini C., Fuchs P.G., Gabrielli F., et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 139 7 (2003) 890-894
27. Alam M., Caldwell J.B., and Eliezri Y.D. Human papillomavirus-associated digital squamous cell carcinoma: literature review and report of 21 new cases. J Am Acad Dermatol 48 3 (2003) 385-393
28. Harwood C.A., Sasieni P., Proby C.M., et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatolol 15 5 (2004) 949-957
29. Casabonne D., Michael K.M., Waterboer T., et al. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European prospective investigation into cancer and nutrition. Int J Cancer 121 8 (2007) 1862-1868
30. Karagas M.R., Nelson H.H., Sehr P., et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98 6 (2006) 389-395
31. Johnson T.M., Rowe D.E., Nelson B.R., et al. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 26 (1992) 467-484
32. Kwa R.E., Campana K., and Moy R.L. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26 (1992) 1-26
33. Euvrard S., Kanitakis J., Decullier E., et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 81 8 (2006) 1093-1100
34. Moloney F.J., Comber H., O'Lorcain P., et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 154 3 (2006 Mar) 498-504
35. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 7 (1993) 431-445
36. Stasko T., Brown M.D., Carucci J.A., et al. International transplant-skin cancer collaborative; European skin care in organ transplant patients network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 30 4 Pt 2 (2004) 642-650
37. Harvelt M.M., Bavinck J.N., Kootte A.M., et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 49 (1990) 506-509
38. Liddington M., Richardson A.J., Higgins R.M., et al. Skin cancer in renal transplant recipients. Br J Surg 76 (1989) 1002-1005
39. Hatton J.L., Parent A., Tober K.L., et al. Depletion of CD4+ cells exacerbates the cutaneous response to acute and chronic UVB exposure. J Invest Dermatol 127 6 (2007) 1507-1515 [Epub 2007 Mar 15]
40. Avaliable at:. www.itscc.org Accessed January 10, 2008
41. Martinez J.C., Otley C.C., Okuno S.H., et al. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations. Dermatol Surg 30 4 Pt 2 (2004) 679-686 [review]
42. Moloney F.J., Kelly P.O., Kay E.W., et al. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg 30 4 Pt 2 (2004) 674-678
43. Otley C.C., and Maragh S.L. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 31 2 (2005) 163-168
44. Harwood C.A., Leedham-Green M., et al. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol 141 4 (2005) 456-464
45. Dinehart S.M., Chu D.Z., Mahers A.W., et al. Immunosuppression in patients with metastatic squamous cell carcinoma from the skin. J Dermatol Surg Oncol 16 (1990) 271-274
46. Boyle J., Mackie R.M., Brigs J.D., et al. Cancer, warts and sunshine in renal transplant patients. A case-control study. Lancet 1 8379 (1984) 702-705
47. George R., Weightman W., Russ G.R., et al. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol 43 4 (2002) 269-273
48. Vajdic C.M., McDonald S.P., McCredie M.R., et al. Cancer incidence before and after kidney transplantation. JAMA 296 23 (2006) 2823-2831
49. Laing M.E., Dicker P., Moloney F.J., et al. Association of methylenetetrahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients. Transplantation 84 1 (2007) 113-116
50. Petter G., and Haustein U.F. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 26 (2000) 521-530
51. Suiqing C., Min Z., and Lirong C. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma. J Dermatol 32 (2005) 354-360
52. Koseki S., Aoki T., Ansai S., et al. An immunohistochemical study of E-cadherin expression in human squamous cell carcinoma of the skin: relationship between decreased expression of E-cadherin in the primary lesion and regional lymph node metastasis. J Dermatol 26 (1999) 416-422
53. Rowe D.E., Carroll R.J., and Day Jr. C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 26 (1992) 976-990
54. Keehn C.A., Smoller B.R., and Morgan M.B. Ets-1 immunohistochemical expression in non-melanoma skin carcinoma. J Cutan Pathol 31 (2004) 8-13
55. Kerkela E., Ala-aho R., Klemi P., et al. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 198 (2002) 258-269
56. Niu Y., Liu F., Zhou Z., et al. Expression of CD44V6 and PCNA in squamous cell carcinomas. Med J 115 (2002) 1564-1568
57. Rodriguez-Rodriguez L., Sancho-Torres I., Gibbon D.G., et al. CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva. J Soc Gynecol Investig 7 (2000) 70-75
58. Brodland D.G., and Zitelli J.A. Mechanism of metastasis. J Am Acad Dermatol 27 (1992) 1-8
59. Weinberg A.S., Ogle C.A., and Shim E.K. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 33 (2007) 885-899
60. Breuniger H., Black B., and Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol 94 (1990) 627-629
61. Kraus D.H., Carew J.F., and Harrison L.B. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol 124 (1998) 582-587
62. Clayman G.L., Lee J.J., Holsinger F.C., et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 23 (2005) 759-765
63. Daniele E., Rodolico V., Leonardi V., et al. Prognosis in lower lip squamous cell carcinoma: assessment of tumor factors. Pathol Res Pract 194 (1998) 319-324
64. Breuninger H., Schaumburg-Lever G., Holzschuh J., et al. Desmoplastic squamous cell carcinoma of skin and vermilion ssurface. Cancer 79 (1997) 915-919
65. Friedman H.I., Cooper P.H., and Wanebo H.J. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 56 (1985) 1099-1105
66. Kirkham N. Tumors and cysts of the epidermis. In: Elder D. (Ed). Lever's histopathology of the skin. 9th edition (2005), Lippincott Williams & Wilkins, Philadelphia
67. Dantal J., Hourmant M., Cantarovich D., et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomized comparison of two cyclosporin regimens. Lancet 351 (1998) 623-628
68. Ross A.S., Delling A., and Schmults C. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 32 (2006) 1309-1321
69. National Cancer Network. Practice guidelines for oncology (squamous cell carcinoma). Ver. 1, January 2008. Available at:. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp Accessed January 12, 2008
70. American Academy of Dermatology Website. Clinical research and guidelines. Available at:. http://www.aad.org/science/guidelines.htm Accessed January 12, 2008
71. Honeycutt W.M., and Jansen G.T. Treatment of squamous cell carcinoma of the skin. Arch Dermatol 108 (1973) 670-672
72. Patel G.K., Goodwin R., Chawla M., et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 54 6 (2006) 1025-1032
73. Peris K., Micantonio T., and Farnoli M. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. J Am Acad Dermatol 55 2 (2006) 324-327
74. Rosen T., Harting M., and Gibson M. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. Dermatol Surg 33 4 (2007) 427-431
75. Nguyen T.H., and Ho D.Q. Nonmelanoma skin cancer. Curr Treat Options Oncol 3 3 (2002) 193-203
76. Sturm H.M. Bowen's disease and 5-fluorouracil. J Am Acad Dermatol 1 (1979) 513-522
77. Smith K.J., Germain M., and Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 27 6 (2000) 561-564
78. Freeman R.G., Knox J.M., and Heaton C.L. The treatment of skin cancer: a statistical study of 1341 skin tumors comparing results obtained with irradiation, surgery, and curettage followed by electrodessication. Cancer 17 (1964) 535-538
79. Brodland D.G., and Zitelli J.A. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 27 (1992) 241-248
80. Drake L.A., Dinehart S.M., Goltz R.W., et al. Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol 33 (1995) 271-278
81. Kimayai-Asadi A., Goldberg L.H., Peterson S.R., et al. The incidence of major complications from Mohs micrographic surgery performed in office-based and hospital-based settings. J Am Acad Dermatol 53 (2005) 628-634
82. Cook J.L., and Perone J.B. A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. Arch Dermatol 139 (2003) 143-152
83. Mohs F.E. Chemosurgery: microscopically controlled surgery for skin cancer (1978), Thomas CC, Springfield (MA)
84. Holmkvist K.A., and Roenigk R.K. Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years. J Am Acad Dermatol 38 (1998) 960-966
85. Lawrence N., and Cottel W. Squamous cell carcinoma of skin with perineural invasion. J Am Acad Dermatol 31 (1994) 30-33
86. Knox J.M., Lyles T.W., Shapiro E.M., et al. Curettage and electrodessication in the treatment of skin cancer. Arch Dermatol 82 (1960) 197-204
87. Whelan C.S., and Deckers P.J. Electrocoagulation for skin cancer: an old oncologic tool revisited. Cancer 47 (1981) 2280-2287
88. Zacarian S.A. Cryosurgery of cutaneous carcinomas. An 18-year study of 3,022 patients with 4,228 carcinomas. J Am Acad Dermatol 9 (1983) 947-956
89. Kuflik E.G., and Gage A.A. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol 24 (1991) 1002-1004
90. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol 6 (1990) 143-148
91. Freeman M., Vinciullo C., Francis D., et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 14 (2003) 99-106
92. Morton C., Horn M., Leman J., et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 142 (2006) 729-735
93. Salim A., Leman J.A., and Chapman R. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 148 3 (2003) 539-543
94. Mazeron J.J., Chassagne D., Crook J., et al. Radiation therapy of carcinomas of the skin of nose and nasal vestibule: a report of 1676 cases by the Groupe Europeen de Curiethérapie. Radiother Oncol 13 (1989) 165-173
95. Petrovich Z., Parker R.G., Luxton G., et al. Carcinoma of the lip and selected sites of head and neck skin. A clinical study of 896 patients. Radiother Oncol 8 (1987) 11-17
96. Lovett R.D., Perez C.A., Shapiro S.J., et al. External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 19 (1990) 235-242
97. Silva J.J., Tsang R.W., Panzarella T., et al. Results of radiotherapy for epithelial skin cancer of the pinna: the princess margaret hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 47 2 (2000) 451-459
98. Locke J., Karimpour S., Young G., et al. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 51 3 (2001) 748-755
99. Morrison W.H., Garden A.S., and And K.K. Radiation therapy for nonmelanoma skin carcinomas. Clin Plast Surg 24 (1997) 719-728
100. Goldman G.D. Squamous cell cancer: a practical approach. Semin Cutan Med Surg 17 2 (1998) 80-95
101. Wollina U., Hansel G., Koch A., et al. Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin. J Cancer Res Clin Oncol 131 5 (2005) 300-308
102. Kaklamani V.G., and Gradishar W.J. Role of capecitabine (Xeloda) in breast cancer. Expert Rev Anticancer Ther 3 (2003) 137-144
103. Tewes M., Schleucher N., and Achterrath W. Capecitabine and irinotecan as first line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study. Ann Oncol 14 (2003) 1442-1448
104. Liegeois N.J., Seo S.J., and Olbricht S.M. Squamous cell carcinoma. In: William H., Bigby M., and Herxheimer A. (Eds). Evidence-based dermatology (2008), BMJ Books, London 248-255